Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Twist Bioscience Corp (TWST)
NASDAQ:TWST
Twist Bioscience (TWST) Stock Price & Analysis
799 Followers
TWST Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$11.46 - $43.21
Previous Close$28.36
Volume142.25K
Average Volume (3M)877.01K
Market Cap
$1.65B
Enterprise Value$1.42B
Total Cash (Recent Filing)$311.14M
Total Debt (Recent Filing)$91.88M
Price to Earnings (P/E)-7.9
Beta2.44
Next Earnings
May 02, 2024EPS Estimate
-$0.82Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.60
Shares Outstanding57,818,022
10 Day Avg. Volume742,843
30 Day Avg. Volume877,010
Standard Deviation0.20
R-Squared0.18
Alpha0.00723
Financial Highlights & Ratios
Price to Book (P/B)3.67
Price to Sales (P/S)6.74
Price to Cash Flow (P/CF)-18.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.95
Enterprise Value/Gross Profit15.83
Enterprise Value/Ebitda-7.81
Forecast
1Y Price Target
$39.29Price Target Upside37.52% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Twist Bioscience News
PremiumCompany Announcements
Twist Bioscience Shareholders Elect Directors, Approve Compensation
Bulls Say, Bears Say
Bulls Say
Financial PerformanceTWST delivered first-quarter revenues of $71.5 million, outperforming expectations and showcasing strong year-over-year growth.
Market PotentialTWST aims to expand its customer base in the lucrative 'DNA makers' market, with a value of approximately $1.4 billion.
Product DemandTWST's Express Genes offering enjoys a pricing premium of 58%, reflecting robust demand for the company's synthetic DNA products.
Bears Say
Financial PerformanceThere remains a concern around visibility into the 55-60% GM target range, especially considering Express Genes is in the early days of launch.
Gross MarginsIt is their SynBio division which has seen the most debate, largely centered on their inability to generate acceptable gross margins.
Stock ValuationRisk/reward skewed to the downside following the recent share price run-up relative to the rest of our coverage universe and remain UW.
---
Ownership Overview
11.65% Insiders
32.88% Mutual Funds
51.26% Other Institutional Investors
4.21% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
TWST FAQ
What was Twist Bioscience Corp’s price range in the past 12 months?
Twist Bioscience Corp lowest stock price was $11.46 and its highest was $43.21 in the past 12 months.
What is Twist Bioscience Corp’s market cap?
Currently, no data Available
When is Twist Bioscience Corp’s upcoming earnings report date?
Twist Bioscience Corp’s upcoming earnings report date is May 02, 2024 which is in 12 days.
How were Twist Bioscience Corp’s earnings last quarter?
Twist Bioscience Corp released its earnings results on Feb 02, 2024. The company reported -$0.75 earnings per share for the quarter, beating the consensus estimate of -$0.777 by $0.027.
Is Twist Bioscience Corp overvalued?
According to Wall Street analysts Twist Bioscience Corp’s price is currently Undervalued.
Does Twist Bioscience Corp pay dividends?
Twist Bioscience Corp does not currently pay dividends.
What is Twist Bioscience Corp’s EPS estimate?
Twist Bioscience Corp’s EPS estimate is -$0.82.
How many shares outstanding does Twist Bioscience Corp have?
Twist Bioscience Corp has 57,818,024 shares outstanding.
What happened to Twist Bioscience Corp’s price movement after its last earnings report?
Twist Bioscience Corp reported an EPS of -$0.75 in its last earnings report, beating expectations of -$0.777. Following the earnings report the stock price went up 10.012%.
Which hedge fund is a major shareholder of Twist Bioscience Corp?
Among the largest hedge funds holding Twist Bioscience Corp’s share is ARK Investment Management LLC. It holds Twist Bioscience Corp’s shares valued at 266M.
---
Twist Bioscience Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$39.29 (37.52% Upside)
$39.29 (37.52% Upside)
Blogger Sentiment
Bullish
TWST Sentiment 80%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Increased
By 440.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $143.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▲ 0.2%
Last 30 Days >0.1%
Last 30 Days >0.1%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
94.35%
12-Months-Change
Fundamentals
Return on Equity
-30.80%
Trailing 12-Months
Asset Growth
-19.47%
Trailing 12-Months
Company Description
Twist Bioscience Corp
Twist Bioscience Corp. develops proprietary semiconductor-based synthetic DNA manufacturing process. It produces synthetic biology tools such as genes, oligo pools, variant libraries, DNA data storage and NGS. The company also produces agriculture production as well as new applications such as in vivo diagnostics, biodetection and data storage. Twist Bioscience was founded by William Marine Banyai, Emily Marine Leproust and Bill James Peck in February 2013 and is headquartered in San Francisco, CA.
---
TWST Company Deck
---
TWST Earnings Call
Q1 2024
0:00 / 0:00
---
TWST Stock 12 Months Forecast
Average Price Target
$39.29
▲(37.52% Upside)
Technical Analysis
Genetic Technologies
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
Editas Medicine
―
Best Analysts Covering TWST
1 Year
1 Year Success Rate
7/20 ratings generated profit
1 Year Average Return
+11.68%
reiterated a buy rating last month
Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 35.00% of your transactions generating a profit, with an average return of +11.68% per trade.
---